Media Top News In The News Media Resources TOP NEWS May 04, 2026Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results March 19, 2026Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment March 02, 2026Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results VIEW ALL WE ARE SOCIAL
